Compounders Research Compare

Quantum Cyber N.V.(QUCY)

Medical - Diagnostics & Research · Mainz

$1.29-0.06 (-4.44%)

Delayed quote: Oct 6, 2026, 1:03 PM EDT

About Quantum Cyber N.V.

Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions. The company pursues acquisitions and partnerships in areas including post-quantum cryptography, zero-trust architecture, and national security technologies. It also develops platforms that integrate artificial intelligence (AI) and quantum computing technologies for autonomous control systems used in unmanned aerial, ground, and underwater vehicles, including drones, self-driving vehicles, and robotic fleets. Quantum Cyber N.V. was formerly known as Mainz Biomed N.V. and changed its name to Quantum Cyber N.V. in April 2026. The company is headquartered in Mainz, Germany.

Mainz

13 employees

quantum-cyber.ai

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: David Elliot Lazar

View full financials

EV/EBIT Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBIT ratio is N/A as of 2026-10-06T17:08:30.943Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:08:30.943Z.

Quote observation: 2026-10-06T17:03:26.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 29,369,758
Total debt · period ending 2026-06-30: 168,670
Cash · period ending 2026-06-30: 13,376,044
TTM operating income · period ending 2026-06-30: -20,399,724

FMP input reference: 8d1468b7a76ea597d68349990a611a16a2ef6f087c77b10e193910d6856baa6d

EV/EBITDA|EV/Sales|Operating Income|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

QUCY EV/EBIT Ratio Metrics

EV/EBIT RATIO

N/A

QUCY Competitors' EV/EBIT Ratio

Quantum Cyber N.V.

Current

Market Cap

$29.37M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OneMedNet Corporation

Market Cap

$29.33M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Context Therapeutics Inc.

Market Cap

$29.50M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GridAI Technologies Corp.

Market Cap

$29.95M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CervoMed Inc.

Market Cap

$30.00M

EV/EBIT Ratio

N/A

TTM Avg

0.37x

3Y Avg

0.82x

5Y Avg

0.82x

BeyondSpring Inc.

Market Cap

$30.34M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

aTyr Pharma, Inc.

Market Cap

$28.49M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDxHealth S.A.

Market Cap

$30.59M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Seres Therapeutics, Inc.

Market Cap

$27.74M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MIRA Pharmaceuticals, Inc.

Market Cap

$31.12M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Quantum Cyber N.V. (QUCY)	$29.37M	N/A	N/A	N/A	N/A
OneMedNet Corporation (ONMD)vs ›	$29.33M	N/A	N/A	N/A	N/A
Context Therapeutics Inc. (CNTX)vs ›	$29.50M	N/A	N/A	N/A	N/A
GridAI Technologies Corp. (GRDX)vs ›	$29.95M	N/A	N/A	N/A	N/A
CervoMed Inc. (CRVO)vs ›	$30.00M	N/A	0.37x	0.82x	0.82x
BeyondSpring Inc. (BYSI)vs ›	$30.34M	N/A	N/A	N/A	N/A
aTyr Pharma, Inc. (ATYR)vs ›	$28.49M	N/A	N/A	N/A	N/A
MDxHealth S.A. (MDXH)vs ›	$30.59M	N/A	N/A	N/A	N/A
Seres Therapeutics, Inc. (MCRB)vs ›	$27.74M	N/A	N/A	N/A	N/A
MIRA Pharmaceuticals, Inc. (MIRA)vs ›	$31.12M	N/A	N/A	N/A	N/A

EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/EBITDA EV/Sales Operating Income All Metrics